Given the ever-changing regulatory environment and market conditions in the Life Sciences space, executive teams must begin preparing for the IPO process well before its official start. This panel discussion is meant to provide important perspectives into the necessary steps that a Life Science executive team should consider 12 to 24 months before a potential filing. Additionally, our panelists will add clarity on the months and weeks before and after an IPO and how the role of a public company executive may differ from that of a private company executive.
While our panelists' agenda will detail a useful timeline of items to consider from a corporate and executive level, there will also be time set aside for your questions.